Patent · US Active

Compounds for preparing immunological adjuvant

US8754236B2 · kind B2 · utility

0Cited by
7References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 22, 2013
Grant dateJun 17, 2014
Priority date
Expiry dateJul 22, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides methods for preparing TLR-4 receptor agonist E6020:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.